Fig. 4From: Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancerRelationship between median lymphocyte density, cellular composition, pathological complete response (pCR) and receptor status. Bar plots illustrating the relationship between pathological complete response, oestrogen receptor (ER) status, human epidermal growth factor receptor 2 (HER2) status, cellular composition and median lymphocyte density. Plots are sorted by increasing level of median lymphocyte density. For illustration, median lymphocyte density has been rescaled to positive valuesBack to article page